| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Tamoxifen | GDSC1000 | pan-cancer | AAC | -0.054 | 0.2 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | 0.056 | 0.2 |
| mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | 0.052 | 0.2 |
| mRNA | JQ12 | GDSC1000 | pan-cancer | AAC | -0.056 | 0.2 |
| mRNA | AZ-3146 | CTRPv2 | pan-cancer | AAC | 0.052 | 0.2 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | -0.069 | 0.2 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.2 |
| mRNA | Axitinib | FIMM | pan-cancer | AAC | 0.22 | 0.2 |
| mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | -0.065 | 0.2 |